Doxil side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Doxil. Common side effects include alopecia among females, and anaemia among males.
The phase IV clinical study is created by eHealthMe based on 10,323 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
10,323 people who take Doxil and have side effects are studied.
What is Doxil?
Doxil has active ingredients of doxorubicin hydrochloride. It is used in ovarian cancer. Currently, eHealthMe is studying from 10,372 Doxil users.
Number of Doxil reports submitted per year:
Doxil side effects by time on the drug *:
Doxil side effects by gender *:
Doxil side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Doxil?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on doxorubicin hydrochloride (the active ingredients of Doxil) and Doxil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Doxil:
- Doxil (10,372 reports)
Common Doxil side effects:
- Hair loss: 2,315 reports
- Pain: 581 reports
- Fatigue (feeling of tiredness): 574 reports
- Thrombocytopenia (decrease of platelets in blood): 551 reports
- Fever: 518 reports
- Weakness: 515 reports
All Doxil side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Diprolene and Altace drug interaction - 2 seconds ago
- Flagyl and Senna Alexandrina drug interaction - 9 seconds ago
- Pradaxa and Breath Odor - 15 seconds ago
- Lo/Ovral and Hyperhidrosis - 15 seconds ago
- Alendronate Sodium and Athlete'S Foot - 19 seconds ago
- Allegra and Spinal Cord Trauma - 43 seconds ago
- Myfortic and Anuria - 44 seconds ago
- Macitentan and Fatigue - 46 seconds ago
- Clexane and Suprane drug interaction - 47 seconds ago
- Prochlorperazine and Micro-K drug interaction - 50 seconds ago